Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 541

1.

Quantitative analysis of Howell-Jolly bodies in children with sickle cell disease.

Harrod VL, Howard TA, Zimmerman SA, Dertinger SD, Ware RE.

Exp Hematol. 2007 Feb;35(2):179-83.

PMID:
17258066
2.

Enumeration of micronucleated CD71-positive human reticulocytes with a single-laser flow cytometer.

Dertinger SD, Torous DK, Hall NE, Murante FG, Gleason SE, Miller RK, Tometsko CR.

Mutat Res. 2002 Mar 25;515(1-2):3-14.

PMID:
11909751
3.

Micronucleated CD71-positive reticulocytes: a blood-based endpoint of cytogenetic damage in humans.

Dertinger SD, Chen Y, Miller RK, Brewer KJ, Smudzin T, Torous DK, Hall NE, Olvany KA, Murante FG, Tometsko CR.

Mutat Res. 2003 Dec 9;542(1-2):77-87.

PMID:
14644356
4.

Quantitative analysis of erythrocytes containing fetal hemoglobin (F cells) in children with sickle cell disease.

Marcus SJ, Kinney TR, Schultz WH, O'Branski EE, Ware RE.

Am J Hematol. 1997 Jan;54(1):40-6.

5.

Fetal hemoglobin in sickle cell anemia: relationship to erythrocyte adhesion markers and adhesion.

Setty BN, Kulkarni S, Dampier CD, Stuart MJ.

Blood. 2001 May 1;97(9):2568-73.

7.

Three-color labeling method for flow cytometric measurement of cytogenetic damage in rodent and human blood.

Dertinger SD, Camphausen K, Macgregor JT, Bishop ME, Torous DK, Avlasevich S, Cairns S, Tometsko CR, Menard C, Muanza T, Chen Y, Miller RK, Cederbrant K, Sandelin K, Pontén I, Bolcsfoldi G.

Environ Mol Mutagen. 2004;44(5):427-35.

PMID:
15517570
8.

Biomarkers of splenic function in infants with sickle cell anemia: baseline data from the BABY HUG Trial.

Rogers ZR, Wang WC, Luo Z, Iyer RV, Shalaby-Rana E, Dertinger SD, Shulkin BL, Miller JH, Files B, Lane PA, Thompson BW, Miller ST, Ware RE; BABY HUG.

Blood. 2011 Mar 3;117(9):2614-7. doi: 10.1182/blood-2010-04-278747. Epub 2011 Jan 7.

9.

Hyposplenism: comparison of different methods for determining splenic function.

Lammers AJ, de Porto AP, Bennink RJ, van Leeuwen EM, Biemond BJ, Goslings JC, van Marle J, ten Berge IJ, Speelman P, Hoekstra JB.

Am J Hematol. 2012 May;87(5):484-9. doi: 10.1002/ajh.23154. Epub 2012 Apr 10.

10.

Altered red cell and platelet adhesion in hemolytic diseases: Hereditary spherocytosis, paroxysmal nocturnal hemoglobinuria and sickle cell disease.

Sakamoto TM, Canalli AA, Traina F, Franco-Penteado CF, Gambero S, Saad ST, Conran N, Costa FF.

Clin Biochem. 2013 Dec;46(18):1798-803. doi: 10.1016/j.clinbiochem.2013.09.011. Epub 2013 Sep 21.

PMID:
24060729
11.

Flow cytometric analysis of micronuclei in peripheral blood reticulocytes: II. An efficient method of monitoring chromosomal damage in the rat.

MacGregor JT, Bishop ME, McNamee JP, Hayashi M, Asano N, Wakata A, Nakajima M, Saito J, Aidoo A, Moore MM, Dertinger SD.

Toxicol Sci. 2006 Nov;94(1):92-107. Epub 2006 Aug 3.

12.

Flow cytometric analysis of micronuclei in peripheral blood reticulocytes III. An efficient method of monitoring chromosomal damage in the beagle dog.

Harper SB, Dertinger SD, Bishop ME, Lynch AM, Lorenzo M, Saylor M, MacGregor JT.

Toxicol Sci. 2007 Dec;100(2):406-14. Epub 2007 Sep 13.

13.

Splenic function in sickle-cell diseases.

Zago MA, Bottura C.

Clin Sci (Lond). 1983 Sep;65(3):297-302.

PMID:
6872464
14.

Howell-Jolly body counting as a measure of splenic function. A reassessment.

Corazza GR, Ginaldi L, Zoli G, Frisoni M, Lalli G, Gasbarrini G, Quaglino D.

Clin Lab Haematol. 1990;12(3):269-75.

PMID:
2125541
15.
16.

Abnormality of erythrocyte membrane n-3 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS).

Ren H, Ghebremeskel K, Okpala I, Ugochukwu CC, Crawford M, Ibegbulam O.

Prostaglandins Leukot Essent Fatty Acids. 2006 Jan;74(1):1-6. Epub 2005 Nov 28.

PMID:
16314081
17.

[Automatic analysis of micronuclei by flow cytometry using anti-CD71-FITC and PI staining].

Yang MJ, Zhou JC, Li Z, Yang XF.

Wei Sheng Yan Jiu. 2005 Jan;34(1):25-8. Chinese.

PMID:
15862014
18.

Evidence for ineffective erythropoiesis in severe sickle cell disease.

Wu CJ, Krishnamurti L, Kutok JL, Biernacki M, Rogers S, Zhang W, Antin JH, Ritz J.

Blood. 2005 Nov 15;106(10):3639-45. Epub 2005 Aug 9.

19.

RBC surface pits in the sickle hemoglobinopathies.

Sills RH, Oski FA.

Am J Dis Child. 1979 May;133(5):526-7.

PMID:
433877
20.

Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease.

Zimmerman SA, Schultz WH, Davis JS, Pickens CV, Mortier NA, Howard TA, Ware RE.

Blood. 2004 Mar 15;103(6):2039-45. Epub 2003 Nov 20.

Items per page

Supplemental Content

Write to the Help Desk